2026-10-25
Tecnoglass clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,816 −5.70%
S&P 7,430 −3.37%
GOLD $4,105 +0.80%
BTC $75,995 −5.48%
VIX 25.68 +54.61%
latest tape · as of 16:02 UTC
The Screen · Basic Materials · Building Materials
Tecnoglass Inc.
TGLS · the NYSE · USD · Market cap $1.9B · 9,601 employees
Tecnoglass Inc.
Not yet scored42.81 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 16:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price42.81 USD at the 4 Nov 2026 close
- Our value readFair vs our fair value, as of 4 Nov 2026
- Our regime readAccumulation, as of 4 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans heavily to calls (put/call 0.29)
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $42.15 to $48.47, base estimate $42.15 (screen dated 2026-11-04).
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.29, read 2026-11-05
- Ethical screen not yet scored
Price42.81 USD
Fair value42.15
Ethical score70.0/100
Value readFairas of 4 Nov 2026
Our investment reviews on this name
2026-10-14Read Accumulation37.57+13.9% to today ✓Markdown gives way to Accumulation after a 7% slide in 4 weeks
2026-09-14Read Markdown40.30+6.2% to today Distribution gives way to Markdown with results news in the headlines
2026-08-14Read Distribution42.03+1.9% to today Markup gives way to Distribution with volume flow in agreement
2026-07-02Read Markup43.79-2.2% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
Tecnoglass Inc. holds its Accumulation at $42.81. Consolidating, no directional conviction, held for 35 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 35 days |
| Price at the screen | $42.81 |
| Valuation | 14.97 trailing · 12.56 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.29 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 13.62% | Below 33% | Interest-bearing debt is just 13.6% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.25% | Below 33% | Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit. | Pass |
| Receivables | 27.00% | Below 49% | Money owed to the company is 27.0% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Tecnoglass clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Tecnoglass clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 14%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 4 Nov 2026: it trades above our $42.15 fair value estimate, 15.60% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. The price runs 1.6% above the base estimate.
Third-party analyst targets: 4 covering, consensus Buy. The average target sits +30% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $42.15, with a range of $42.15 to $48.47, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsGlass maker numbers look solid but cycle lurks
Picture a construction boom that suddenly stalls when interest rates bite and projects get postponed. Tecnoglass supplies the architectural glass and aluminium frames that fill those buildings across Colombia and the US. Revenue is growing 12 percent, margins sit at 15 percent and return on equity reaches 21 percent, all on a forward multiple of 13 times. The ethical screen clears without issue.
Yet this remains a classic cyclical business where peak earnings often coincide with the lowest multiples. The shares trade above our fair value estimate and carry no opportunity rating, so the apparent cheapness may simply reflect the next downturn rather than a bargain. Analyst targets sit higher but offer little comfort when demand can swing sharply with housing and commercial spending.
Risk centres on that economic sensitivity plus limited visibility into any durable moat. Currency moves between Colombia and the US add another layer of volatility that can erode reported profits quickly. Analysis, not advice.
| Forward P/E | 12.6xfairly priced for its growth rate |
| Trailing P/E | 15.0xreasonably valued |
| EPS, trailing | 2.86 |
| EPS, forward | 3.41 |
| Revenue growth | +15.6%steady growth |
| Profit margin | 12.4%thin but positive margins |
| Return on equity | 17.0%a solid return on shareholder capital |
| FCF yield | -1.17% |
| Dividend yield | 137.00% |
| Debt to equity | 0.29minimal debt: a conservative balance sheet |
| Current ratio | 1.86healthy short-term liquidity |
| Beta | 1.29moves a little more than the market |
| Short interest, float | 0.13% |
| 52-week range | 34.05 - 57.53 |
| Market cap | $1.9B |
| Employees | 9,601 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTGLS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-05
Accumulation $42.81
+8.1% Entry 17
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04
Accumulation $39.62
+2.9% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03
Accumulation $38.51
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $38.51
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation $38.51
+0.5% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Accumulation $38.30
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Accumulation $38.30
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Accumulation $38.30
+1.6% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $37.69
+0.9% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57.
2026-10-21
Accumulation $37.35
-0.6% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (3 analysts) rates it none, with a mean price target of $57.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 low-volatility stocks with questionable fundamentals Yahoo Finance · 7d ago
- 1 Stock Under $50 with Exciting Potential and 2 We Question Yahoo Finance · 14d ago
- Tecnoglass Sets Date for Third Quarter 2026 Results Yahoo Finance · 14d ago
- Tecnoglass (TGLS): Buy, Sell, or Hold Post Q2 Earnings? Yahoo Finance · 17d ago
- Tecnoglass Holdings (TGLS) Is Up 8.1% After U.S. Redomiciliation And Expansion Plans - What's Changed Yahoo Finance · 25d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
TTAMTitan America SA
LOMALoma Negra Compañía Industrial Argentina Sociedad Anónima
CPACCementos Pacasmayo S.A.A.
KNFKnife River Corporation
USLMUnited States Lime & Minerals, Inc.
RMIXSuncrete, Inc.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $38.69 | +8.8% | · | $1,088 | +8.8% |
| 2 months | $43.59 | -3.4% | · | $966 | -3.4% |
| 3 months | $44.61 | -5.7% | $0.15 | $947 | -5.3% |
| 6 months | $53.30 | -21.0% | $0.15 | $792 | -20.8% |
| 1 year | $87.57 | -51.9% | $0.30 | $484 | -51.6% |
| 2 years | $45.15 | -6.8% | $0.82 | $950 | -5.0% |
| 3 years | $42.26 | -0.4% | $1.20 | $1,024 | +2.4% |
| 5 years | $21.79 | +93.1% | $1.69 | $2,009 | +100.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TGLS does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.